VistaGen Therapeutics, Inc.VTGNNASDAQ
Loading
Year-over-year operating cash flow growth rate
| Period | Value |
|---|---|
| Q4 2025 | -28.14% |
| Q3 2025 | 26.99% |
| Q2 2025 | -87.30% |
| Q1 2025 | 2.12% |
| Q4 2024 | 5.57% |
| Q3 2024 | -0.16% |
| Q2 2024 | -51.02% |
| Q1 2024 | -51.61% |
| Q4 2023 | 23.31% |
| Q3 2023 | 21.56% |
| Q2 2023 | -5.60% |
| Q1 2023 | 24.77% |
| Q4 2022 | 39.21% |
| Q3 2022 | -2.33% |
| Q2 2022 | -2.44% |
| Q1 2022 | -29.41% |
| Q4 2021 | -5.20% |
| Q3 2021 | -85.48% |
| Q2 2021 | -16.87% |
| Q1 2021 | -5.88% |
| Q4 2020 | -597.02% |
| Q3 2020 | 135.76% |
| Q2 2020 | -8.82% |
| Q1 2020 | 39.73% |
| Q4 2019 | -3.45% |
| Q3 2019 | 13.12% |
| Q2 2019 | -33.85% |
| Q1 2019 | 8.96% |
| Q4 2018 | 0.52% |
| Q3 2018 | -25.28% |
| Q2 2018 | -20.42% |
| Q1 2018 | -6.50% |
| Q4 2017 | -30.33% |
| Q3 2017 | 12.10% |
| Q2 2017 | -64.95% |
| Q1 2017 | 38.25% |
| Q4 2016 | 4.85% |
| Q3 2016 | -31.78% |
| Q2 2016 | -27.60% |
| Q1 2016 | -11.99% |